Omid Farokhzad: From Tehran to the Edge of Nanomedicine

Through advancements in proteomic technologies, Farokhzad and his teams aim to revolutionize the early detection of illnesses such as cancer, neurodegenerative disorders, and metabolic conditions. By identifying faint biological signals long before symptoms appear, these innovations make it possible to envision a healthcare system where prevention and early intervention are the norm rather than the exception.